Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin

被引：0
|
作者：
Mück W. [1 ,2 ]
Adelmann H.-G. [1 ]
Ruf T. [1 ]
Unger S. [1 ]
Voith B. [1 ]
机构：
[1] Institute of Clinical Pharmacology, Bayer AG, Wuppertal
[2] Institute of Clinical Pharmacology, Bayer AG, Pharma Research Center, D-42096 Wuppertal, Aprather Weg
来源：
Clinical Drug Investigation | 2000年 / 19卷 / 1期
关键词：
Pravastatin; Orlistat; Cerivastatin; Maximum Observe Plasma Concentration; Reduce Serum Cholesterol Level;
D O I：
10.2165/00044011-200019010-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：71 / 73
页数：2
相关论文
共 50 条
  • [1] Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin
    Mück, W
    Adelmann, HG
    Ruf, T
    Unger, S
    Voith, B
    [J]. CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 71 - 73
  • [2] Lack of drug-drug interaction between cerivastatin and nifedipine
    Sachse, R
    Brendel, E
    Muck, W
    Rohde, G
    Ochmann, K
    Horstmann, R
    Kuhlmann, J
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (08) : 409 - 413
  • [3] No drug-drug interaction between cerivastatin and omeprazole
    Mück, W
    Ochmann, K
    Rohde, G
    Unger, S
    Kuhlmann, J
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R175 - R175
  • [4] No drug-drug interaction between cerivastatin and nifedipine
    Sachse, R
    Brendel, E
    Mück, W
    Rohde, G
    Ochmann, K
    Horstmann, R
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R174 - R174
  • [5] There is no drug-drug interaction between cerivastatin and nifedipine
    [J]. Reactions Weekly, 1998, 715 (1) : 4 - 4
  • [6] Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin
    Nave, R
    Drollmann, A
    Steinijans, VW
    Zech, K
    Bethke, TD
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (06) : 264 - 270
  • [7] Mechanism of clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
    Shitara, Y
    Hirano, M
    Sato, H
    Sugiyama, Y
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 : 297 - 297
  • [8] Lack of Drug-Drug Interaction between Maribavir and Voriconazole
    Song, I. H.
    Ilic, K.
    Wu, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 779 - 779
  • [9] Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors
    Wang, Ding
    Braiteh, Fadi
    Lee, James J.
    Denlinger, Crystal S.
    Shepard, Dale R.
    Chaudhary, Archana
    Lin, Yong
    Gao, Ling
    Asakiewicz, Christopher
    Nasroulah, Federico
    LoRusso, Patricia
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 727 - 733
  • [10] Multiple drugsSupratherapeutic drug levels following drug-drug pharmacokinetic interaction and lack of efficacy
    [J]. Reactions Weekly, 2024, 2003 (1) : 638 - 638
12345